What is the recommended treatment for a patient with non-ulcer dyspepsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Non-Ulcer Dyspepsia

All patients with non-ulcer dyspepsia (functional dyspepsia) should first undergo H. pylori testing and receive eradication therapy if positive, followed by empirical proton pump inhibitor therapy if H. pylori-negative or symptoms persist, with tricyclic antidepressants reserved as second-line treatment. 1

Initial Diagnostic Approach

  • Test all patients for H. pylori infection using non-invasive testing (urea breath test or stool antigen) and provide eradication therapy if positive, as this is the only treatment that may alter the natural history of the condition 1
  • Perform full blood count in patients aged ≥55 years and coeliac serology in those with overlapping IBS-type symptoms 1
  • Reserve urgent endoscopy only for patients aged ≥55 years with weight loss, or those aged >40 years from high gastric cancer risk areas or with family history of gastro-oesophageal cancer 1

First-Line Pharmacological Treatment

For H. pylori-Positive Patients

  • Eradication therapy is highly efficacious (strong recommendation, high-quality evidence), though adverse events are more common than control therapy 1
  • Confirm successful eradication only in patients at increased risk of gastric cancer 1

For H. pylori-Negative Patients or Persistent Symptoms

  • Proton pump inhibitors (PPIs) are the first-line treatment (strong recommendation, high-quality evidence) 1
  • Use the lowest effective dose that controls symptoms, as there is no dose-response relationship 1
  • PPIs are well-tolerated and superior to H2-receptor antagonists, which have only weak evidence (weak recommendation, low-quality evidence) 1

Second-Line Treatment for Refractory Symptoms

Prokinetic Agents (for postprandial distress symptoms)

  • Consider prokinetics only after H. pylori eradication and PPI trial have failed 2
  • Acotiamide 100 mg three times daily is the preferred first-line prokinetic based on robust clinical trial data and long-term safety evidence 2
  • Itopride is an alternative if acotiamide is unavailable or unaffordable 2
  • Cintapride may be chosen for patients with overlapping GERD symptoms, but avoid combining with QT-prolonging agents 2
  • Tegaserod has strong evidence (strong recommendation, moderate-quality evidence) but limited availability 1
  • Note: Many prokinetics are unavailable outside Asia and the USA 1, 2

Tricyclic Antidepressants (TCAs)

  • TCAs are efficacious second-line treatment (strong recommendation, moderate-quality evidence) when first-line therapies fail 1
  • Start amitriptyline at 10 mg once daily at bedtime and titrate slowly to maximum 30-50 mg once daily 1
  • Provide careful explanation that these are used as gut-brain neuromodulators, not for depression 1
  • Counsel patients about side effect profile before initiating 1

Non-Pharmacological Management

  • Advise all patients to take regular aerobic exercise (strong recommendation) 1
  • Establish an empathic doctor-patient relationship with shared understanding of the condition, which may reduce healthcare utilization and improve quality of life 1
  • Explain that functional dyspepsia is a disorder of gut-brain interaction with a chronic, fluctuating course affecting approximately two-thirds of patients long-term 3
  • Discuss common symptom triggers and the gut-brain axis, including how diet, stress, and emotional responses impact symptoms 1
  • There is insufficient evidence to recommend specific dietary therapies, including low-FODMAP diets 1

Referral Criteria

  • Refer to gastroenterology when there is diagnostic doubt, severe symptoms, refractoriness to first-line treatments, or patient request for specialist opinion 1
  • Ideally, manage referred patients in specialist clinics with access to dietetic support, efficacious drugs, and gut-brain behavioral therapies 1

Critical Pitfalls to Avoid

  • Do not use prokinetics as first-line therapy—PPIs have stronger evidence and should be tried first 2
  • Do not routinely perform gastric emptying testing or 24-hour pH monitoring in patients with typical functional dyspepsia symptoms 1
  • Avoid opioids or surgery for refractory symptoms to minimize iatrogenic harm 3
  • Counsel patients that prokinetics work best for meal-related symptoms (early satiety, postprandial fullness) rather than epigastric pain 2
  • Involve dietitians early if food restriction develops to prevent overly restrictive diets 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prokinetic Selection for Postprandial Distress Syndrome (PDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prognosis of Post-Infectious Functional Dyspepsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.